| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $2.2M | +5.7% |
| SG&A Expense | $6.5M | -6.4% |
| Operating Income | -$8.7M | +3.5% |
| Interest Expense | $13K | -70.2% |
| Net Income | -$8.7M | +4.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.8M | -79.8% |
| Current Assets | $1.9M | -78.8% |
| Total Assets | $2.1M | -76.4% |
| Current Liabilities | $2.0M | -31.2% |
| Total Liabilities | $2.1M | -27.6% |
| Stockholders' Equity | -$11K | -100.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.1M | -4.4% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $0 | -100.0% |